Aquarius Surgical Technologies Inc.
ASTI
CNSX
12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
---|---|---|---|---|---|
Revenue | 80.60K | 112.40K | 130.90K | 152.30K | 153.80K |
Total Other Revenue | -- | -- | -- | -- | -- |
Total Revenue | 80.60K | 112.40K | 130.90K | 152.30K | 153.80K |
Cost of Revenue | 39.10K | 53.30K | 45.60K | 53.60K | 58.60K |
Gross Profit | 41.50K | 59.10K | 85.30K | 98.70K | 95.20K |
SG&A Expenses | 458.30K | 417.30K | 449.90K | 439.10K | 449.50K |
Depreciation & Amortization | 22.00K | 22.50K | 23.00K | 22.90K | 21.10K |
Other Operating Expenses | -- | -- | -- | -- | -- |
Total Operating Expenses | 519.40K | 493.10K | 518.50K | 515.60K | 529.20K |
Operating Income | -438.90K | -380.80K | -387.70K | -363.40K | -375.40K |
Income Before Tax | -654.80K | -616.80K | -580.10K | -555.20K | -474.10K |
Income Tax Expenses | 5.20K | 5.20K | 5.20K | 6.70K | 1.50K |
Earnings from Continuing Operations | -0.66 | -0.62 | -0.59 | -0.56 | -0.48 |
Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
Minority Interest in Earnings | -- | -- | -- | -- | -- |
Net Income | -660.00K | -622.00K | -585.30K | -561.80K | -475.50K |
EBIT | -438.90K | -380.80K | -387.70K | -363.40K | -375.40K |
EBITDA | -426.70K | -368.10K | -374.50K | -350.40K | -362.60K |
EPS Basic | -0.02 | -0.02 | -0.02 | -0.02 | -0.02 |
Normalized Basic EPS | -0.02 | -0.01 | -0.01 | -0.01 | -0.01 |
EPS Diluted | -0.02 | -0.02 | -0.02 | -0.02 | -0.02 |
Normalized Diluted EPS | -0.02 | -0.01 | -0.01 | -0.01 | -0.01 |
Average Basic Shares Outstanding | 110.40M | 110.40M | 110.40M | 110.40M | 110.35M |
Average Diluted Shares Outstanding | 110.40M | 110.40M | 110.40M | 110.40M | 110.35M |
Dividend Per Share | -- | -- | -- | -- | -- |
Payout Ratio | -- | -- | -- | -- | -- |